“I am giving WeGreened (WG) team a 5-star review for my petition’s approval without any RFE. WG team’s remote communication system is very efficient. They guarantee to draft time for the recommendation letters and petition letters. They also perform several rounds of quality checks and they can even catch very minor discrepancies before filing. This team deserves your trust in your immigration journey.”

Case Summary:

When a research scientist II from China hired us to help him in documenting his I-140 NIW (National Interest Waiver) petition back in 2020, we made sure of his credentials and reviewed his proposed research background. We were certain that our unprecedented knowledge in building employment-based visa petitions will gain him the national interest waiver. We proved it right as his NIW petition achieved approval in less than 7 months after we filed his case.

Our satisfied client decided to retain our law firm for filing another petition under the I-140 EB1B (Outstanding Professors and Researchers) visa category since many petitioners get more than one petition filed to increase their chances to move faster to receiving the green card success. Thus, we began accumulating further evidence required for his EB-1B case.

Even though NIW and EB1B are two unique petitions, a few attributes remain the same; the client’s research brief and its impacting factors to the interests of the United States, the publishing record, and citation count. Also, the client’s active participation in the peer review activity. Thus, we outlined the most important aspects of our client’s EB1B case i.e., his research focus on developing new pharmaceutical drugs to prevent and treat life-threatening diseases. We deduced how his research improves disease diagnostics and drug development, as well as how to develop novel drug delivery systems and nano-medicine innovations, confirming that his research is of the utmost importance to major health-related concerns in the United States.

The distinctive point that we highlighted in his EB1B case was his major funding sources; affirmatively his work received funding support from the National Institutes of Health and the United States Department of Defense, therefore, this demonstrates that his work has clearly been recognized as valuable to the national security of the United States.

Also, our aim was to signify his outstanding academic and professional skills set, hence we further included that our client held a Ph.D. in pharmaceutical sciences and published 13 peer-reviewed journal articles in high impact and internationally circulated journals in the field, which altogether accumulated 138 citations from many researchers hailing from several prestigious and widespread institutes in Korea, Denmark, Netherlands, Turkey, Japan, and South Africa, among others. This apparently authenticates the international influence of our client’s work, as well as global implementation of it in the field. Not only did he accomplish his elite level in the field by publishing but also conducted peer reviews, proving his active and actual participation as a judge of the work of other experts in the field. We noted that he had already conducted 80 peer reviews at the time of filing for the petitions.

“[Client] has considerably added value to the existing literature on pharmaceutical sciences through his substantial publication history. He has authored a dozen articles in top-tier scientific journals. These journals only accept exceptional submissions that cover topics on the cutting-edge of research in pharmaceutical sciences. The inclusion of his papers in these periodicals, therefore, highlights the relevance of his work and distinguishes it as being of superior quality.”

The aforementioned excerpt has been contributed by one of his five well-reputed recommenders, concluding that our client has established himself as an instrumental figure within the field of pharmaceutical sciences, and his work has had a resounding influence on the medical community at large. Accordingly, his current research in the United States must continue unimpeded.

We are glad that our client obtained both the petition approvals in the span of 28 days with our team’s efficient efforts in his cases. Our client upgraded his EB-1B case to premium processing, therefore, the case got approved just 7 days after we filed the petition. However, the best part is he got the I-485 approvals even before his EB1B petition approval. We would like to thank him for letting us help him in achieving his green card success. We wish him well in his future endeavors.